Published in Gastrointest Endosc Clin N Am on July 01, 2003
Barrett's esophagus and the increasing role of endoluminal therapy. Therap Adv Gastroenterol (2008) 1.11
Endoscopic therapy for Barrett's oesophagus. Gut (2005) 0.82
Endoscopic therapy of Barrett's: what more do we need to know? Gut (2004) 0.75
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol (2007) 11.04
Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med (2009) 6.31
Endoscopic treatment for Zenker's diverticulum: long-term results (with video). Gastrointest Endosc (2013) 4.30
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. J Clin Oncol (2009) 3.61
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data. Hepatology (2014) 3.30
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab. J Clin Oncol (2009) 2.92
The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology (2009) 2.92
Endoscopic drainage of pancreatic-fluid collections in 116 patients: a comparison of etiologies, drainage techniques, and outcomes. Gastrointest Endosc (2006) 2.79
Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc (2010) 2.57
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. J Clin Oncol (2007) 2.47
Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc (2011) 2.30
Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol (2009) 2.28
Pancreatic-fluid collections: a randomized controlled trial regarding stent removal after endoscopic transmural drainage. Gastrointest Endosc (2007) 2.17
Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg (2008) 2.06
A case series of symptomatic intraluminal duodenal duplication cysts: presentation, endoscopic therapy, and long-term outcome (with video). Gastrointest Endosc (2008) 2.06
Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer. Clin Cancer Res (2013) 2.03
Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology (2004) 2.02
EUS-guided pancreatogastrostomy and pancreatobulbostomy for the treatment of pain in patients with pancreatic ductal dilatation inaccessible for transpapillary endoscopic therapy. Gastrointest Endosc (2007) 2.01
CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology (2005) 1.88
Endoscopic removal of dysfunctioning bands or rings after restrictive bariatric procedures. Gastrointest Endosc (2009) 1.84
Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol (2003) 1.84
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study. Clin Cancer Res (2008) 1.80
Endoscopic treatment of external pancreatic fistulas: when draining the main pancreatic duct is not enough. Am J Gastroenterol (2007) 1.74
Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc (2004) 1.72
Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology (2006) 1.68
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Gastroenterology (2012) 1.67
Clinical impact of biliary drainage and jaundice resolution in patients with obstructive metastases at the hilum. Am J Gastroenterol (2003) 1.67
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma. Clin Cancer Res (2009) 1.62
Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months. Gastrointest Endosc (2005) 1.62
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol (2010) 1.61
EUS-guided pancreaticogastrostomy. Gastrointest Endosc (2002) 1.50
Endoscopic cystenterostomy of nonbulging pancreatic fluid collections. Gastrointest Endosc (2002) 1.50
Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology (2011) 1.49
Reduced medication dependency and improved symptoms and quality of life 12 months after enteryx implantation for gastroesophageal reflux. J Clin Gastroenterol (2005) 1.46
Self-expandable metal stents for the treatment of benign upper GI leaks and perforations. Gastrointest Endosc (2011) 1.42
Microsatellite polymorphism in the heme oxygenase-1 gene promoter is not associated with alcoholic liver disease severity. Hepatology (2013) 1.39
Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol (2011) 1.23
EUS-guided cholecystenterostomy: a new technique (with videos). Gastrointest Endosc (2007) 1.21
Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol (2002) 1.20
Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol (2002) 1.18
Long-term clinical outcome after endoscopic pancreatic ductal drainage for patients with painful chronic pancreatitis. Clin Gastroenterol Hepatol (2004) 1.18
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas. BMC Cancer (2010) 1.10
Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. Cancer (2010) 1.09
Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today? Oncologist (2009) 1.05
Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. J Hepatol (2013) 1.01
Endoscopic treatment of acute variceal hemorrhage by using hemostatic powder TC-325: a prospective pilot study. Gastrointest Endosc (2013) 1.01
Propofol, the preferred sedation for screening colonoscopy, is underused. Results of an international survey. Dig Liver Dis (2011) 0.99
MR imaging of the pancreas: a pictorial tour. Radiographics (2002) 0.98
Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients. BMC Cancer (2010) 0.98
A prospective comparative study of push and wireless-capsule enteroscopy in patients with obscure digestive bleeding. Acta Gastroenterol Belg (2003) 0.97
Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology (2002) 0.96
Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Surg Innov (2012) 0.96
Zenker's diverticulum: a new endoscopic treatment with a soft diverticuloscope. Gastrointest Endosc (2003) 0.94
Initial evaluation of a novel prototype forward-viewing US endoscope in transmural drainage of pancreatic pseudocysts (with videos). Gastrointest Endosc (2007) 0.94
Endoscopic management of chronic pancreatitis. Gastrointest Endosc Clin N Am (2003) 0.93
The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families. Gut (2009) 0.92
Evaluation of tumor necrosis factor-alpha, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of sepsis without shock. Clin Microbiol Infect (1997) 0.92
Endoscopic magnetic gastroenteric anastomosis for palliation of malignant gastric outlet obstruction: a prospective multicenter study. Gastrointest Endosc (2010) 0.91
Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer. Pancreas (2008) 0.91
MR cholangiography with manganese dipyridoxyl diphosphate in the evaluation of biliary-enteric anastomoses: preliminary experience. AJR Am J Roentgenol (2005) 0.91
Effectiveness of Endoscopic Management Using Self-Expandable Metal Stents in a Large Cohort of Patients with Post-bariatric Leaks. Obes Surg (2015) 0.90
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study. BMC Cancer (2009) 0.90
Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. J Hepatol (2010) 0.87
Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. Acta Gastroenterol Belg (2011) 0.87
Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents. Hepatology (2008) 0.87
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group. J Clin Oncol (2005) 0.87
Management of anticoagulants before and after endoscopy. Can J Gastroenterol (2003) 0.87
Chronic alcohol exposure sensitizes mice to galactosamine-induced liver injury through enhanced keratinocyte chemoattractant and defective IL-10 production. J Hepatol (2003) 0.87
Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis. J Hepatol (2011) 0.86
Endoscopic management of pancreatic fistula after pancreatic and other abdominal surgery. Best Pract Res Clin Gastroenterol (2004) 0.86
Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc (2011) 0.85
Endoscopic technique for the management of pancreatitis and its complications. Best Pract Res Clin Gastroenterol (2004) 0.85
Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol (2006) 0.85
Erosion of a retroesophageal subclavian artery by an esophageal prosthesis. J Thorac Cardiovasc Surg (2006) 0.84
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer. Semin Oncol (2005) 0.84
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study. Int J Radiat Oncol Biol Phys (2005) 0.83
Endoscopic complications--avoidance and management. Nat Rev Gastroenterol Hepatol (2012) 0.83
Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease. Eur J Gastroenterol Hepatol (2015) 0.82
Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results. Radiology (2008) 0.82
Distal esophageal spasm treated by peroral endoscopic myotomy. Am J Gastroenterol (2012) 0.82
Endoscopic implantation of enteryx for the treatment of gastroesophageal reflux disease: technique, pre-clinical and clinical experience. Gastrointest Endosc Clin N Am (2003) 0.81
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). J Gastrointest Cancer (2015) 0.81
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. Eur J Cancer (2013) 0.81
Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects. Ann Nutr Metab (2012) 0.81
Ensocopic-endoluminal therapies. A critical appraisal. Best Pract Res Clin Gastroenterol (2010) 0.81
The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice. Am J Pathol (2012) 0.80
Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis. Liver Transpl (2003) 0.80
Preconditioning of donors with interleukin-10 reduces hepatic ischemia-reperfusion injury after liver transplantation in pigs. Transplantation (2003) 0.79
Adjuvant chemotherapy for colorectal cancer. Curr Gastroenterol Rep (2002) 0.79
Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer. Drugs Aging (2013) 0.79
Predictive factors for survival in patients with inoperable Klatskin tumors. Hepatogastroenterology (2006) 0.78
Correction of all-trans retinoic acid deficiency in alcoholic cirrhosis lessens the excessive inflammatory monocyte response: a translational study. Liver Int (2013) 0.78
Disconnected pancreatic tail syndrome: a plea for multidisciplinarity. Gastrointest Endosc (2008) 0.78
Enteryx. Best Pract Res Clin Gastroenterol (2004) 0.77
Magnetic resonance imaging in the detection of pancreatitis and pancreatic neoplasms. Best Pract Res Clin Gastroenterol (2006) 0.77